W Y Weiser

1.8k total citations
32 papers, 1.4k citations indexed

About

W Y Weiser is a scholar working on Immunology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, W Y Weiser has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Immunology, 7 papers in Epidemiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in W Y Weiser's work include Macrophage Migration Inhibitory Factor (16 papers), Research on Leishmaniasis Studies (6 papers) and Vitamin K Research Studies (4 papers). W Y Weiser is often cited by papers focused on Macrophage Migration Inhibitory Factor (16 papers), Research on Leishmaniasis Studies (6 papers) and Vitamin K Research Studies (4 papers). W Y Weiser collaborates with scholars based in United States, Switzerland and Germany. W Y Weiser's co-authors include John R. David, Heinz G. Remold, S C Clark, HG Remold, J Witek-Giannotti, Patricia A. Temple, Sheldon C. Engelhorn, Steven Gillis, Frederik B. Bang and Lu-Ann M. Pozzi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

W Y Weiser

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Y Weiser United States 18 827 269 223 186 177 32 1.4k
Ana Clara Abadía‐Molina Spain 19 960 1.2× 141 0.5× 108 0.5× 75 0.4× 188 1.1× 37 1.3k
Joanne Sonstein United States 25 724 0.9× 106 0.4× 340 1.5× 19 0.1× 218 1.2× 35 1.4k
Sachin Mulik United States 18 655 0.8× 206 0.8× 319 1.4× 18 0.1× 336 1.9× 30 1.3k
Manthrasalam Rengaraju United States 8 1.3k 1.6× 93 0.3× 289 1.3× 14 0.1× 165 0.9× 10 1.7k
Mei Mei Ho United Kingdom 22 381 0.5× 72 0.3× 298 1.3× 60 0.3× 516 2.9× 64 1.5k
Shoutaro Tsuji Japan 22 1.1k 1.4× 62 0.2× 356 1.6× 35 0.2× 566 3.2× 68 2.0k
G. L. Mandell United States 17 360 0.4× 111 0.4× 120 0.5× 32 0.2× 237 1.3× 31 910
Kiyotoshi Mori Japan 6 881 1.1× 77 0.3× 190 0.9× 17 0.1× 280 1.6× 10 1.2k
E R Unanue United States 14 1.3k 1.6× 76 0.3× 150 0.7× 23 0.1× 352 2.0× 17 1.9k
J A Schmidt United Kingdom 13 528 0.6× 94 0.3× 150 0.7× 36 0.2× 647 3.7× 26 1.3k

Countries citing papers authored by W Y Weiser

Since Specialization
Citations

This map shows the geographic impact of W Y Weiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Y Weiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Y Weiser more than expected).

Fields of papers citing papers by W Y Weiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Y Weiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Y Weiser. The network helps show where W Y Weiser may publish in the future.

Co-authorship network of co-authors of W Y Weiser

This figure shows the co-authorship network connecting the top 25 collaborators of W Y Weiser. A scholar is included among the top collaborators of W Y Weiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Y Weiser. W Y Weiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jorand‐Lebrun, Catherine, Jing‐Jer Lin, Robert Murray, et al.. (2006). Identification, synthesis, and biological evaluation of novel pyrazoles as low molecular weight luteinizing hormone receptor agonists. Bioorganic & Medicinal Chemistry Letters. 17(7). 2080–2085. 34 indexed citations
2.
3.
Layman, Lawrence C., et al.. (2002). FSHβ Gene Mutations in a Female with Partial Breast Development and a Male Sibling with Normal Puberty and Azoospermia. The Journal of Clinical Endocrinology & Metabolism. 87(8). 3702–3707. 95 indexed citations
4.
Lass, Amir, W Y Weiser, Alain Munafo, & Ernest Loumaye. (2001). Leukemia inhibitory factor in human reproduction. Fertility and Sterility. 76(6). 1091–1096. 83 indexed citations
5.
Novick, Daniela, Roustem Nabioullin, Sean D. McKenna, et al.. (2000). The Neutralization of Type I IFN Biologic Actions by Anti-IFNAR-2 Monoclonal Antibodies Is Not Entirely Due to Inhibition of Jak-Stat Tyrosine Phosphorylation. Journal of Interferon & Cytokine Research. 20(11). 971–982. 18 indexed citations
6.
Smith‐Norowitz, Tamar A., Jacob Shani, W Y Weiser, et al.. (1999). Lymphocyte Activation in Angina Pectoris. Clinical Immunology. 93(2). 168–175. 12 indexed citations
7.
Weiser, W Y, et al.. (1993). The Major Binding Protein of the Interferon Antagonist Sarcolectin in Human Placenta Is a Macrophage Migration Inhibitory Factor. Archives of Biochemistry and Biophysics. 303(1). 74–80. 53 indexed citations
8.
9.
Wu, Jiayi, Fernando Q. Cunha, F Y Liew, & W Y Weiser. (1993). IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation.. The Journal of Immunology. 151(8). 4325–4332. 57 indexed citations
10.
Mikayama, Toshifumi, T Nakano, Hiromichi Gomi, et al.. (1993). Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.. Proceedings of the National Academy of Sciences. 90(21). 10056–10060. 45 indexed citations
11.
Kayser, Klaus, et al.. (1993). Alteration of human lung parenchyma associated with primary biliary cirrhosis.. PubMed. 139(4-5). 377–80. 3 indexed citations
12.
Pozzi, Lu-Ann M. & W Y Weiser. (1992). Human recombinant migration inhibitory factor activates human macrophages to kill tumor cells. Cellular Immunology. 145(2). 372–379. 34 indexed citations
13.
Engelhorn, Sheldon C., et al.. (1989). Il 4 abrogates the activation of human cultured monocytes by ifn gamma. The FASEB Journal. 3(3). 822. 1 indexed citations
14.
Weiser, W Y, et al.. (1989). IL-4 inhibits H2O2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-gamma.. The Journal of Immunology. 143(9). 3020–3024. 201 indexed citations
15.
David, John R., et al.. (1988). Identification and Characterization of a Non-Interferon Antileishmanial Macrophage Activating Factor (Antileishmanial MAF). Advances in experimental medicine and biology. 239. 231–237. 2 indexed citations
16.
Weiser, W Y, et al.. (1987). Recombinant human granulocyte/macrophage colony-stimulating factor activates intracellular killing of Leishmania donovani by human monocyte-derived macrophages.. The Journal of Experimental Medicine. 166(5). 1436–1446. 156 indexed citations
17.
Rose, Richard M., et al.. (1986). Deficient Responses of Pulmonary Macrophages from Healthy Smokers to Antiviral Lymphokines in Vitro. The Journal of Infectious Diseases. 154(4). 611–618. 17 indexed citations
18.
Taylor, Claire, W Y Weiser, & Frederik B. Bang. (1981). In vitro macrophage manifestation of cortisone-induced decrease in resistance to mouse hepatitis virus.. The Journal of Experimental Medicine. 153(3). 732–737. 9 indexed citations
19.
Weiser, W Y & Frederik B. Bang. (1977). Blocking of in vitro and in vivo susceptibility to mouse hepatitis virus.. The Journal of Experimental Medicine. 146(5). 1467–1472. 18 indexed citations
20.
Weiser, W Y & Frederik B. Bang. (1976). Macrophages genetically resistant to mouse hepatitis virus converted in vitro to susceptible macrophages.. The Journal of Experimental Medicine. 143(3). 690–695. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Clara Abadía‐Molina Breakdown of academic impact, for papers by Joanne Sonstein Breakdown of academic impact, for papers by Sachin Mulik Breakdown of academic impact, for papers by Manthrasalam Rengaraju Breakdown of academic impact, for papers by Mei Mei Ho Breakdown of academic impact, for papers by Shoutaro Tsuji Breakdown of academic impact, for papers by G. L. Mandell Breakdown of academic impact, for papers by Kiyotoshi Mori Breakdown of academic impact, for papers by E R Unanue Breakdown of academic impact, for papers by J A Schmidt
Rankless by CCL
2026